Drug intelligence / Profile preview

Yinqiao Huozhu Granule

Development stage: Unknown
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration: Oral

Overview

Yinqiao Huozhu Granule is a Traditional Chinese Medicine (TCM) formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is primarily indicated for the treatment of gastrointestinal cold characterized by heat-dampness syndrome, as well as the common cold. The formulation is designed to clear heat, resolve the exterior, and transform dampness, addressing symptoms such as fever, gastrointestinal distress, and respiratory discomfort. It is currently being evaluated in clinical trials to assess its efficacy and safety compared to standard treatments like Huoxiang Zhengqi Soft Capsule.

Other names: Yinqiao Huozhu Keli

Beyond the preview

Go deeper on Yinqiao Huozhu Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinqiao Huozhu Granule.

Explore the full profile